Advertisement
Canada markets open in 8 hours 53 minutes
  • S&P/TSX

    21,848.59
    +293.69 (+1.36%)
     
  • S&P 500

    5,447.87
    -16.75 (-0.31%)
     
  • DOW

    39,411.21
    +260.91 (+0.67%)
     
  • CAD/USD

    0.7328
    +0.0005 (+0.06%)
     
  • CRUDE OIL

    81.68
    +0.05 (+0.06%)
     
  • Bitcoin CAD

    83,640.73
    -2,122.04 (-2.47%)
     
  • CMC Crypto 200

    1,272.10
    -37.62 (-2.87%)
     
  • GOLD FUTURES

    2,338.40
    -6.00 (-0.26%)
     
  • RUSSELL 2000

    2,030.81
    +8.78 (+0.43%)
     
  • 10-Yr Bond

    4.2480
    -0.0090 (-0.21%)
     
  • NASDAQ futures

    19,792.75
    +42.00 (+0.21%)
     
  • VOLATILITY

    13.33
    +0.13 (+0.98%)
     
  • FTSE

    8,281.55
    +43.83 (+0.53%)
     
  • NIKKEI 225

    39,035.98
    +231.33 (+0.60%)
     
  • CAD/EUR

    0.6822
    +0.0004 (+0.06%)
     

Here’s What Eli Lilly’s Latest Clinical Win Means For Investors

Here’s What Eli Lilly’s Latest Clinical Win Means For Investors

Few pharmaceutical giants have performed as well or better than Eli Lilly (NYSE: LLY) in the stock market over the past year. The Indianapolis-based company's secret wasn't its financial results, as they were relatively mild, or even downright disappointing, for much of this period. The market is forward-looking, and with the drugmaker producing several highly promising programs, investors are increasingly excited regarding Eli Lilly's future.